Acute Myeloid Leukemia — Trials

Acute Myeloid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

2,964 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 789
Recruiting: 466
Ph III recruiting: 45
Growth YoY: +3.7%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 39%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (536)

clinicaltrialsPublishedShowing 151–200 of 1,290 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04802161	Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes	active not recruiting	Phase 2	49	National Cancer Institute (NCI)NIH	1	Jun 30, 2026	clinicaltrials
NCT07597941	Lisaftoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients	not yet recruiting	Phase 2 / Phase 3	20	The Affiliated People's Hospital of Ningbo UniversityOTHER_GOV